Suivre
Abonner AC Immune SA

AC Immune SA

Filtre
  • 07.12.2006 – 10:40

    Genentech and AC Immune: Exclusive License Agreement

    AC Immune, Ltd. enters into an Exclusive Global License Agreement and Research Collaboration with Genentech, Inc. for Development of Anti-beta-amyloid Antibodies for the Potential Treatment of Alzheimer's Disease and other human Diseases. Ecublens/Lausanne, Switzerland (ots) - AC Immune, Ltd., a Swiss Biotech Company developing innovative therapies against Alzheimer's Disease, today announced that it has entered into ...

  • 11.05.2005 – 10:30

    AC Immune raises CHF 21 million in private financing round

    Ecublens/Lausanne (ots) - AC Immune, a Swiss biotech company developing innovative therapies against Alzheimer's disease, today announced that it has successfully completed its round B financing raising CHF 21 million from private and strategic investors. The financing goal of CHF 21 millions was achieved with 2/3 of the invested capital contributed by new investors. AC immune is focused on new therapies for the ...